Vise Technologies’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Vise Technologies’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,976	Closed	-$261K	–	328
2022 Q1	$261K	Buy	+13,976	New	+$251K	0.1%	194

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vise Technologies's OCDX Position: Q2 2022 in Review

Vise Technologies sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 13,976 shares — an estimated $261K sold.

Vise Technologies first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $261K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Vise Technologies reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Vise Technologies sold 13,976 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $261K.
Vise Technologies first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
Vise Technologies's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $261K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Vise Technologies's 13F filing for Q2 2022, filed 15 Aug 2022.